Ashley Bourgeois, PA
Medical · Ocean Springs, MSNPI 1316403934
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.9% of the total across 321 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations.
Across 321 payments — averaging $20.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Sanofi$851
- Sun Pharmaceutical Industries Inc.$505
- Johnson & Johnson$486
- Novartis$383
- Arcutis Biotherapeutics, Inc.$292
- plus $3K from 27 others
What the payments were for
- Food & beverage$6,29595%
- Education$3405%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 65 | $1,066 |
| Sanofi | 46 | $851 |
| Sun Pharmaceutical Industries Inc. | 22 | $505 |
| Johnson & Johnson | 20 | $486 |
| Novartis | 18 | $383 |
| Arcutis Biotherapeutics, Inc. | 12 | $292 |
| Organogenesis Inc. | 10 | $291 |
| Incyte Corporation | 9 | $283 |
| UCB, Inc. | 12 | $270 |
| Lilly USA, LLC | 12 | $266 |
| LEO Pharma Inc. | 10 | $211 |
| Amgen | 9 | $185 |
| Galderma Laboratories, L.p. | 11 | $179 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 10 | $162 |
| E.r. Squibb & Sons, L.L.C. | 6 | $156 |
| Pfizer | 9 | $146 |
| Mallinckrodt Hospital Products Inc. | 4 | $139 |
| Almirall LLC | 6 | $127 |
| Regeneron Healthcare Solutions, Inc. | 6 | $125 |
| Sanofi-aventis U.S. LLC | 2 | $104 |
| Organon | 4 | $80 |
| Journey Medical Corporation | 4 | $67 |
| Biofrontera Inc. | 2 | $41 |
| Dermavant Sciences, Inc. | 2 | $37 |
| Kowa Pharmaceuticals America, Inc. | 2 | $34 |
| Revance Therapeutics, Inc. | 1 | $26 |
| Boehringer Ingelheim | 1 | $21 |
| ALON Medical Technology | 1 | $20 |
| Cipher Pharmaceuticals US LLC | 1 | $17 |
| Dermira, Inc. | 1 | $17 |
| Botanix SB Inc | 1 | $17 |
| EPI Health, LLC | 1 | $16 |
| VYNE Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,635 in reported general payments places this provider in the 85th percentile of 65 medical providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TremfyaGuselkumab | 14 | $184,758 |
| Humira(Cf) PenAdalimumab | 13 | $165,235 |
| Cosentyx Unoready PenSecukinumab | 13 | $88,424 |
| Dupixent PenDupilumab | 15 | $56,926 |
| Clobetasol Propionate | 71 | $2,904 |
| Betamethasone Dipropionate | 54 | $2,417 |
| Ketoconazole | 143 | $1,636 |
| Fluorouracil | 23 | $1,415 |
| Triamcinolone Acetonide | 78 | $1,256 |
| Mupirocin | 116 | $933 |
| Doxycycline Hyclate | 52 | $913 |
| Clindamycin Phosphate | 37 | $857 |
| Fluocinonide | 19 | $791 |
| ValacyclovirValacyclovir Hcl | 29 | $519 |
| Hydrocortisone | 38 | $415 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonTremfya | $486 | $184,75814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 65 medical providers in Mississippi.
Other medical in Ocean Springs
- Ashley LarsenOcean Springs$11K
- Mark GriffithOcean Springs$2K
- Melissa SinopoliOcean Springs$1K
- Matthew DykesOcean Springs$389
- Carrie GrantOcean Springs$377
- Angelle LoweryOcean Springs$347
- Tyson GibsonOcean Springs$212
- Shannon YoungerColumbus$63K
- Angela DauroBiloxi$25K
- Jenna HabermanFlowood$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.